M&A Deal Summary

Immucor Acquires Hologic - LIFECODES business

On January 3, 2013, Immucor acquired life science company Hologic - LIFECODES business from Hologic for 85M USD

Acquisition Highlights
  • This is Immucor’s 1st transaction in the Life Science sector.
  • This is Immucor’s largest (disclosed) transaction.
  • This is Immucor’s 1st transaction in the United States.

M&A Deal Summary
Date 2013-01-03
Target Hologic - LIFECODES business
Sector Life Science
Buyer(s) Immucor
Sellers(s) Hologic
Deal Type Divestiture
Deal Value 85M USD

Target

Hologic - LIFECODES business

United States
Hologic - LIFECODES business includes transplantation diagnostics. LIFECODES sells molecular and antibody-based assays in the markets of transplant diagnostics, specialty coagulation and transfusion medicine.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Immucor

Norcross, Georgia, United States
Category Company
Sector Medical Products
DESCRIPTION

Immucor, Inc. manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories, and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor is based in Norcross, Georgia.

DEAL STATS #
Overall 1 of 5
Sector (Life Science) 1 of 2
Type (Divestiture) 1 of 1
Country (United States) 1 of 5
Year (2013) 1 of 2
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-03-22 Gen-Probe Holdings

Stamford, Connecticut, United States

Gen-Probe Holdings, Inc. is a manufacturer, and seller of reagents and automated systems used primarily by hospitals, clinical labs.

Buy -

Seller(S) 1

SELLER

Hologic

Marlborough, Massachusetts, United States
Category Company
Founded 1985
Sector Medical Products
Employees6,944
Revenue 4.0B USD (2023)
DESCRIPTION
Hologic's corporate headquarters in Marlborough, Massachusetts.
Hologic's corporate headquarters in Marlborough, Massachusetts.

Hologic is a developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women throughout the world. Hologic was formed in 1985 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 2 of 4
Sector (Life Science) 2 of 2
Type (Divestiture) 2 of 4
Country (United States) 2 of 4
Year (2013) 1 of 1
Size (of disclosed) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-08-01 Gen-Probe

San Diego, California, United States

Gen-Probe, Inc., is a provider in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility.

Buy $3.8B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-12-14 Hologic - NAT

United States

Hologic - NAT (Nucleic Acid Testing) is the most advanced technology for the detection of infectious agents in blood and plasma donations because they are much more sensitive in detecting viral infections and reducing the so-called window period, interval between donor exposure to a virus and production of antibodies against the virus. In terms of diagnostic, NAT tests reduce this window period, increasing the diagnostics transfusion safety.

Sell $1.9B
Mergr

Product

Company

Legal